Retatrutide is an investigational synthetic peptide designed as a triple receptor agonist targeting GLP-1, GIP and glucagon receptors. It has been developed for research into metabolic signalling, energy regulation and glucose-related pathways. Laboratory and clinical research has explored its effects on multiple interconnected metabolic mechanisms and receptor pathways.
Reviews
There are no reviews yet.